ProQR Therapeutics N.V.
PRQR
$1.47
-$0.06-3.92%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -52.43M | -47.68M | -47.22M | -43.26M | -32.34M |
| Total Depreciation and Amortization | 3.14M | 3.05M | 2.98M | 2.95M | 2.95M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.02M | 4.71M | 2.99M | 2.32M | 1.23M |
| Change in Net Operating Assets | -12.31M | -19.50M | -12.58M | -7.76M | -11.39M |
| Cash from Operations | -55.58M | -59.42M | -53.83M | -45.75M | -39.54M |
| Capital Expenditure | -1.11M | -1.16M | -689.70K | -806.50K | -979.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -2.83M | 15.86M | 15.86M |
| Cash from Investing | -1.11M | -1.16M | -3.52M | 15.05M | 14.88M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.64M | -1.91M | -1.56M | -1.57M | -1.57M |
| Issuance of Common Stock | 2.00K | 69.00K | 71.75M | 71.75M | 71.76M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.90M | -2.08M | 74.76M | 74.79M | 74.81M |
| Foreign Exchange rate Adjustments | -664.50K | -1.49M | -745.70K | -896.10K | 139.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -59.26M | -64.14M | 16.67M | 43.19M | 50.29M |